SCHEMBL29385240

SCHEMBL29385240

C[C@H]1CNCCCN1S(=O)(=O)c1cccc2c(F)nccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK1 Q13464 8/20 0.58
▸ ROCK2 O75116 7/20 0.58
▸ PRKCD Q05655 6/20 0.58
▸ PKN2 Q16513 3/20 0.58
▸ AURKB Q96GD4 3/20 0.58
▸ PRKD2 Q9BZL6 3/20 0.58
▸ PLK4 O00444 2/20 0.58
▸ MARK3 P27448 2/20 0.58
▸ PRKAA1 Q13131 2/20 0.58
▸ MARK2 Q7KZI7 2/20 0.58
▸ NQO2 P16083 2/20 0.58
▸ CDK9 P50750 2/20 0.58
▸ PKN1 Q16512 2/20 0.58
▸ MAP2K3 P46734 1/20 0.58
▸ PRKAG1 P54619 1/20 0.58
▸ MAP4K3 Q8IVH8 1/20 0.58
▸ TAOK3 Q9H2K8 1/20 0.58
▸ PRKACA P17612 5/20 0.57
▸ PRKD3 O94806 4/20 0.57
▸ PRKACG P22612 4/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23795402 0.87 PRKCD (0.57) ROCK1ROCK2PRKCDPKN2AURKB
SCHEMBL30439459 0.87 PRKCD (0.57) ROCK1ROCK2PRKCDPKN2AURKB
SCHEMBL30439363 0.87 PRKCD (0.57) ROCK1ROCK2PRKCDPKN2AURKB
SCHEMBL23795296 0.87 PRKCD (0.57) ROCK1ROCK2PRKCDPKN2AURKB
SCHEMBL19350236 0.87 PRKCD (0.57) ROCK1ROCK2PRKCDPKN2AURKB
Hydrochloric Acid SCHEMBL23795390 0.86 PRKCD (0.58) ROCK1ROCK2PRKCDPKN2AURKB
Hydrochloric Acid SCHEMBL23795335 0.86 PRKCD (0.58) ROCK1ROCK2PRKCDPKN2AURKB
Hydrochloric Acid SCHEMBL30439323 0.86 PRKCD (0.58) ROCK1ROCK2PRKCDPKN2AURKB
Hydrochloric Acid SCHEMBL30438942 0.86 PRKCD (0.58) ROCK1ROCK2PRKCDPKN2AURKB
SCHEMBL23795417 0.85 PRKCD (0.55) ROCK1ROCK2PRKCDPKN2AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124250-A1 METHODS FOR SELECTING CULTURED CORNEAL ENDOTHELIAL CELLS UNIV MAASTRICHT (NL) 2026-05-07 — — US disclosed
EP-4655392-A2 METHODS FOR SELECTING CULTURED CORNEAL ENDOTHELIAL CELLS Universiteit Maastricht (NL) 2025-12-03 — — EP disclosed
WO-2024158290-A2 METHODS FOR SELECTING CULTURED CORNEAL ENDOTHELIAL CELLS UNIVERSITEIT MAASTRICHT (NL) 2024-08-02 — — WO disclosed
WO-2022025239-A1 METHOD FOR ENHANCING THERAPEUTIC EFFECT OF CORNEAL ENDOTHELIAL CELL INJECTION THERAPY 学校法人同志社 2022-02-03 — — WO disclosed
WO-2022025240-A1 METHOD AND VESSEL FOR PRESERVING CORNEAL ENDOTHELIAL CELLS 学校法人同志社 2022-02-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124250-A1 METHODS FOR SELECTING CULTURED CORNEAL ENDOTHELIAL CELLS TAGLN2, CNN2, TMIGD3 ROCK1 810/4885ROCK2 580/4885PRKCD 2455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback